Alberto Zacchetti

Tumor initiating cells: Development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension

Ileana Bortolomai, Silvana Canevari, Ileana Facetti et al. · Cell Cycle · 2010 · 75 citations · Full text

Medicine, Cell Biology, Oncology +16

Validation of the use of proliferation markers in canine neoplastic and non‐neoplastic tissues: comparison of KI‐67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry

Alberto Zacchetti, E. van Garderen, Erik Teske et al. · Apmis · 2003 · 74 citations

Veterinary Medicine, Oncology, Veterinary Pathology +17

90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas

Angela Coliva, Alberto Zacchetti, Elena Luison et al. · Cancer Immunology Immunotherapy · 2005 · 41 citations · Full text

Medicine, Immunology, Oncology +14

177Lu- labeled MOv18 as compared to 131I- or 90Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts

Alberto Zacchetti, Angela Coliva, Elena Luison et al. · Nuclear Medicine and Biology · 2009 · 28 citations

Medicine, Oncology, Pharmacology +11

Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor

Mariangela Figini, Franck Martin, Renata Ferri et al. · Cancer Immunology Immunotherapy · 2008 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +16